Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1995 Sep;50(Suppl 1):S37–S42. doi: 10.1136/thx.50.suppl_1.s37

Escalating threat from tuberculosis: the third epidemic.

A S Malin 1, K P McAdam 1
PMCID: PMC1129014  PMID: 7570462

Full text

PDF
S37

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alland D., Kalkut G. E., Moss A. R., McAdam R. A., Hahn J. A., Bosworth W., Drucker E., Bloom B. R. Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med. 1994 Jun 16;330(24):1710–1716. doi: 10.1056/NEJM199406163302403. [DOI] [PubMed] [Google Scholar]
  2. Bloom B. R., Murray C. J. Tuberculosis: commentary on a reemergent killer. Science. 1992 Aug 21;257(5073):1055–1064. doi: 10.1126/science.257.5073.1055. [DOI] [PubMed] [Google Scholar]
  3. Brudney K., Dobkin J. Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis. 1991 Oct;144(4):745–749. doi: 10.1164/ajrccm/144.4.745. [DOI] [PubMed] [Google Scholar]
  4. Daley C. L., Small P. M., Schecter G. F., Schoolnik G. K., McAdam R. A., Jacobs W. R., Jr, Hopewell P. C. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N Engl J Med. 1992 Jan 23;326(4):231–235. doi: 10.1056/NEJM199201233260404. [DOI] [PubMed] [Google Scholar]
  5. De Cock K. M., Soro B., Coulibaly I. M., Lucas S. B. Tuberculosis and HIV infection in sub-Saharan Africa. JAMA. 1992 Sep 23;268(12):1581–1587. doi: 10.1001/jama.268.12.1581. [DOI] [PubMed] [Google Scholar]
  6. Edlin B. R., Tokars J. I., Grieco M. H., Crawford J. T., Williams J., Sordillo E. M., Ong K. R., Kilburn J. O., Dooley S. W., Castro K. G. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med. 1992 Jun 4;326(23):1514–1521. doi: 10.1056/NEJM199206043262302. [DOI] [PubMed] [Google Scholar]
  7. Eisenach K. D. Use of an insertion sequence for laboratory diagnosis and epidemiologic studies of tuberculosis. Ann Emerg Med. 1994 Sep;24(3):450–453. doi: 10.1016/s0196-0644(94)70182-2. [DOI] [PubMed] [Google Scholar]
  8. Fischl M. A., Daikos G. L., Uttamchandani R. B., Poblete R. B., Moreno J. N., Reyes R. R., Boota A. M., Thompson L. M., Cleary T. J., Oldham S. A. Clinical presentation and outcome of patients with HIV infection and tuberculosis caused by multiple-drug-resistant bacilli. Ann Intern Med. 1992 Aug 1;117(3):184–190. doi: 10.7326/0003-4819-117-3-184. [DOI] [PubMed] [Google Scholar]
  9. Godfrey-Faussett P., Mortimer P. R., Jenkins P. A., Stoker N. G. Evidence of transmission of tuberculosis by DNA fingerprinting. BMJ. 1992 Jul 25;305(6847):221–223. doi: 10.1136/bmj.305.6847.221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hawken M., Nunn P., Gathua S., Brindle R., Godfrey-Faussett P., Githui W., Odhiambo J., Batchelor B., Gilks C., Morris J. Increased recurrence of tuberculosis in HIV-1-infected patients in Kenya. Lancet. 1993 Aug 7;342(8867):332–337. doi: 10.1016/0140-6736(93)91474-z. [DOI] [PubMed] [Google Scholar]
  11. Hopewell P. C. Impact of human immunodeficiency virus infection on the epidemiology, clinical features, management, and control of tuberculosis. Clin Infect Dis. 1992 Sep;15(3):540–547. doi: 10.1093/clind/15.3.540. [DOI] [PubMed] [Google Scholar]
  12. Horn D. L., Hewlett D., Jr, Haas W. H., Butler W. R., Alfalla C., Tan E., Levine A., Nayak A., Opal S. M. Superinfection with rifampin-isoniazid-streptomycin-ethambutol (RISE)-resistant tuberculosis in three patients with AIDS: confirmation by polymerase chain reaction fingerprinting. Ann Intern Med. 1994 Jul 15;121(2):115–116. doi: 10.7326/0003-4819-121-2-199407150-00007. [DOI] [PubMed] [Google Scholar]
  13. Iseman M. D., Cohn D. L., Sbarbaro J. A. Directly observed treatment of tuberculosis. We can't afford not to try it. N Engl J Med. 1993 Feb 25;328(8):576–578. doi: 10.1056/NEJM199302253280811. [DOI] [PubMed] [Google Scholar]
  14. Iseman M. D. Treatment of multidrug-resistant tuberculosis. N Engl J Med. 1993 Sep 9;329(11):784–791. doi: 10.1056/NEJM199309093291108. [DOI] [PubMed] [Google Scholar]
  15. Jacobs W. R., Jr, Barletta R. G., Udani R., Chan J., Kalkut G., Sosne G., Kieser T., Sarkis G. J., Hatfull G. F., Bloom B. R. Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. Science. 1993 May 7;260(5109):819–822. doi: 10.1126/science.8484123. [DOI] [PubMed] [Google Scholar]
  16. Kochi A., Vareldzis B., Styblo K. Multidrug-resistant tuberculosis and its control. Res Microbiol. 1993 Feb;144(2):104–110. doi: 10.1016/0923-2508(93)90023-u. [DOI] [PubMed] [Google Scholar]
  17. Kumaresan J. A., Maganu E. T. Case holding in patients with tuberculosis in Botswana. BMJ. 1992 Aug 8;305(6849):340–341. doi: 10.1136/bmj.305.6849.340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lucas S. B., Hounnou A., Peacock C., Beaumel A., Djomand G., N'Gbichi J. M., Yeboue K., Hondé M., Diomande M., Giordano C. The mortality and pathology of HIV infection in a west African city. AIDS. 1993 Dec;7(12):1569–1579. doi: 10.1097/00002030-199312000-00005. [DOI] [PubMed] [Google Scholar]
  19. Murray C. J., DeJonghe E., Chum H. J., Nyangulu D. S., Salomao A., Styblo K. Cost effectiveness of chemotherapy for pulmonary tuberculosis in three sub-Saharan African countries. Lancet. 1991 Nov 23;338(8778):1305–1308. doi: 10.1016/0140-6736(91)92600-7. [DOI] [PubMed] [Google Scholar]
  20. Nunn P. P., Elliott A. M., McAdam K. P. Tropical respiratory medicine. 2. Impact of human immunodeficiency virus on tuberculosis in developing countries. Thorax. 1994 May;49(5):511–518. doi: 10.1136/thx.49.5.511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Pape J. W., Jean S. S., Ho J. L., Hafner A., Johnson W. D., Jr Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet. 1993 Jul 31;342(8866):268–272. doi: 10.1016/0140-6736(93)91817-6. [DOI] [PubMed] [Google Scholar]
  22. Pearson M. L., Jereb J. A., Frieden T. R., Crawford J. T., Davis B. J., Dooley S. W., Jarvis W. R. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. A risk to patients and health care workers. Ann Intern Med. 1992 Aug 1;117(3):191–196. doi: 10.7326/0003-4819-117-3-191. [DOI] [PubMed] [Google Scholar]
  23. Small P. M., Hopewell P. C., Singh S. P., Paz A., Parsonnet J., Ruston D. C., Schecter G. F., Daley C. L., Schoolnik G. K. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N Engl J Med. 1994 Jun 16;330(24):1703–1709. doi: 10.1056/NEJM199406163302402. [DOI] [PubMed] [Google Scholar]
  24. Snider D. E., Jr, Roper W. L. The new tuberculosis. N Engl J Med. 1992 Mar 5;326(10):703–705. doi: 10.1056/NEJM199203053261011. [DOI] [PubMed] [Google Scholar]
  25. Tabet S. R., Goldbaum G. M., Hooton T. M., Eisenach K. D., Cave M. D., Nolan C. M. Restriction fragment length polymorphism analysis detecting a community-based tuberculosis outbreak among persons infected with human immunodeficiency virus. J Infect Dis. 1994 Jan;169(1):189–192. doi: 10.1093/infdis/169.1.189. [DOI] [PubMed] [Google Scholar]
  26. Tartaglia J., Pincus S., Paoletti E. Poxvirus-based vectors as vaccine candidates. Crit Rev Immunol. 1990;10(1):13–30. [PubMed] [Google Scholar]
  27. Valway S. E., Richards S. B., Kovacovich J., Greifinger R. B., Crawford J. T., Dooley S. W. Outbreak of multi-drug-resistant tuberculosis in a New York State prison, 1991. Am J Epidemiol. 1994 Jul 15;140(2):113–122. doi: 10.1093/oxfordjournals.aje.a117222. [DOI] [PubMed] [Google Scholar]
  28. Vareldzis B. P., Grosset J., de Kantor I., Crofton J., Laszlo A., Felten M., Raviglione M. C., Kochi A. Drug-resistant tuberculosis: laboratory issues. World Health Organization recommendations. Tuber Lung Dis. 1994 Feb;75(1):1–7. doi: 10.1016/0962-8479(94)90096-5. [DOI] [PubMed] [Google Scholar]
  29. Weis S. E., Slocum P. C., Blais F. X., King B., Nunn M., Matney G. B., Gomez E., Foresman B. H. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med. 1994 Apr 28;330(17):1179–1184. doi: 10.1056/NEJM199404283301702. [DOI] [PubMed] [Google Scholar]
  30. Wilkinson D. High-compliance tuberculosis treatment programme in a rural community. Lancet. 1994 Mar 12;343(8898):647–648. doi: 10.1016/s0140-6736(94)92640-9. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES